The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia
Launched by UNIVERSITY OF MODENA AND REGGIO EMILIA · Jan 23, 2024
Trial Information
Current as of June 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia," is focused on understanding the challenges faced by individuals who have recently been diagnosed with cancer and completed their initial treatment. The study aims to gather insights from patients, their caregivers, and healthcare stakeholders to improve aftercare services for cancer survivors. By talking to people who have experienced various types of cancer, including breast, prostate, and colorectal cancers, the researchers want to identify gaps in support and care that could enhance the well-being of survivors in the region.
To participate in this study, individuals must be at least 18 years old and have a history of specific cancers, like breast or prostate cancer, and have completed their main treatment. Caregivers and stakeholders who support these patients are also welcome to join. Participants can expect to share their experiences through focus groups or interviews, which will be recorded to accurately capture their thoughts. This information will be analyzed to find ways to make aftercare better for cancer survivors, ensuring their needs are met as they continue their recovery journey.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult aged18 years or over.
- • Individuals who have a history of breast, prostate, thyroid, colorectal, multiple myeloma or lymphoma cancer within the past years who have completed the acute phase of treatment, and are in follow-up or are receiving maintenance treatment;
- • Caregivers for an individual who meets the above criteria, who are aged 18 years or over.
- • Stakeholders for individual who meets the above criteria, who are aged 18 years or over.
- Exclusion Criteria:
- • Individuals who do not wish to participate
- • Individuals who do not understand and/or speak Italian
- • Individuals with significant cognitive impairment, learning difficulty, or communication difficulty such that understanding the nature of the study, the interview questions, or participating in a focus group or an on-line or in-presence interview would not be practical.
About University Of Modena And Reggio Emilia
The University of Modena and Reggio Emilia, a prestigious institution located in Italy, is renowned for its commitment to advancing medical research and education. With a strong focus on innovation and interdisciplinary collaboration, the university plays a pivotal role in conducting clinical trials that aim to improve healthcare outcomes. Its dedicated team of researchers and clinicians are engaged in cutting-edge studies across various medical fields, fostering an environment that encourages scientific inquiry and the translation of research findings into clinical practice. The university's robust infrastructure and emphasis on ethical standards ensure the integrity and reliability of its clinical trials, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Reggio Emilia, , Italy
Patients applied
Trial Officials
Stefania Costi, PhD
Principal Investigator
Physical Medicine and Rehabilitation Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported